15/10/02说明:此前论坛服务器频繁出错,现已更换服务器。今后论坛继续数据库备份,不备份上传附件。

肝胆相照论坛

 

 

肝胆相照论坛 论坛 学术讨论& HBV English 严格的停药标准可提高拉米夫定治疗的持久性 ...
查看: 721|回复: 1
go

严格的停药标准可提高拉米夫定治疗的持久性 [复制链接]

Rank: 8Rank: 8

现金
4865 元 
精华
帖子
1027 
注册时间
2004-11-2 
最后登录
2020-4-2 
1
发表于 2011-8-4 10:54 |只看该作者 |倒序浏览 |打印
严格的停药标准可提高拉米夫定治疗的持久性:在乙肝病毒核心抗原阳性的慢性乙肝患者中进行的一项前瞻性临床试验
The cessation criteria for lamivudine treatment vary in published articles and their results are contradictory, especially factors predicting relapse. To clarify these contradictions, this long-term follow-up study of 125 Chinese hepatitis B e antigen (HBeAg)-positive chronic hepatitis B patients was designed with stringent cessation criterion. All patients received lamivudine and achieved HBeAg seroconversion (group A, n = 82) or loss (group B, n = 43) with undetectable hepatitis B virus (HBV) DNA by PCR assay during the treatment. Lamivudine was withdrawn ≥6 months after HBeAg seroconversion/loss occurred. The median treatment durations were 24 (12-54) months and 36 (18-89) months in group A and group B, respectively. Patients were followed up for median 24 (2-84) months. The cumulative relapse (defined as serum HBV DNA ≥10 4 copies/mL) rates in the two groups at months 12, 24, 36 and 48 were 23.4%vs 35.0%, 25.0%vs 37.7%, 25.0%vs 41.1% and 29.4%vs 41.1%, respectively (log-rank test, P = 0.119). For patients whose total treatment duration ≥18 months in group A, the cumulative relapse rates at months 12, 24, 36 and 48 were 18.3%, 20.1%, 20.1% and 25.1%, which was significantly lower than those with a shorter duration (log-rank test, P = 0.002). The mean age and median total duration were statistically different between relapsers and nonrelapsers in group A (33.9 ± 13.6 vs 23.1 ± 11.0 years, P < 0.001 and 24 vs 26 months, P = 0.003). Cox regression revealed that age was the only predictive factor for relapse (RR, 1.069; 95% CI, 1.032-1.106, P < 0.001). Patients aged <30 years relapsed less frequently in 5 years (12.3%vs 53.5%, P = 0.001). In conclusion, for patients who maintained HBeAg seroconversion for ≥6 months and total duration for ≥18 months, lamivudine withdrawal is a reasonable option. Prolonged treatment may be required for patients aged greater than 30 years to reduce relapse. © 2009 Blackwell Publishing Ltd.

Rank: 5Rank: 5

现金
1638 元 
精华
帖子
1152 
注册时间
2011-2-2 
最后登录
2016-1-14 
2
发表于 2011-8-4 11:36 |只看该作者
不懂 英文
下次检查,DNA  阴,表面抗原 阴,E抗原 阴,核心抗体 阴,表面抗体阳,  E抗原阴,他妈的这么多年,原来我压根没有乙肝,都是误检...            ...
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册

肝胆相照论坛

GMT+8, 2024-5-20 05:01 , Processed in 0.017153 second(s), 10 queries , Gzip On.

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.